SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-14-023268
Filing Date
2014-01-28
Accepted
2014-01-28 08:16:00
Documents
8
Period of Report
2014-01-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d665213d8k.htm 8-K 20996
2 EX-5.1 d665213dex51.htm EX-5.1 10051
3 EX-10.1 d665213dex101.htm EX-10.1 71527
4 EX-10.2 d665213dex102.htm EX-10.2 37265
5 EX-99.1 d665213dex991.htm EX-99.1 7445
6 GRAPHIC g665213ex5_1footer.jpg GRAPHIC 15208
7 GRAPHIC g665213ex5_1logo.jpg GRAPHIC 2530
8 GRAPHIC g665213ex99_1logo.jpg GRAPHIC 14153
  Complete submission text file 0001193125-14-023268.txt   192915
Mailing Address 320 BENT STREET CAMBRIDGE MA 02141
Business Address 320 BENT STREET CAMBRIDGE MA 02141 617-995-9800
IDENIX PHARMACEUTICALS INC (Filer) CIK: 0001093649 (see all company filings)

IRS No.: 450478605 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-49839 | Film No.: 14550679
SIC: 2834 Pharmaceutical Preparations